Global Anti-CD20 Monoclonal Antibodies (mAbs) Market Assessment, By Product Type [First Generation CD20 Monoclonal Antibodies, Second Generation CD20 Monoclonal Antibodies, Third Generation CD20 Monoclonal Antibodies], By Indication [Oncology, Neuroscience, Immunology, Others], By End-user [Hospitals, Specialty Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F